Sjogren's syndrome: Too many associations, too limited evidence. The enigmatic example of CNS involvement

Seminars in Arthritis and Rheumatism

Volumn 29, Issue 1, 1999, Pages 1-3

  Ioannidis, J P A ^a   Moutsopoulos, H M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROSPINAL FLUID ANALYSIS; DIAGNOSTIC IMAGING; DISEASE PREDISPOSITION; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; REVIEW; SJOEGREN SYNDROME; CENTRAL NERVOUS SYSTEM DISEASE; FEMALE; HUMAN; NOTE; PROGNOSIS;

CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; HUMANS; PREVALENCE; PROGNOSIS; SJOGREN'S SYNDROME;

EID: 0032589249     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-0172(99)80032-8     Document Type: Article

References (22)

1. Niemelä R.K. Hakala M. Primary Sjögren's syndrome with severe central nervous system disease Semin Arthritis Rheum 29 1999 4 13
2. Alexander E.L. Neuromuscular complications of primary Sjögren's syndrome Talal N. Moutsopoulos H.M. Kassan S.S. Sjögren's syndrome: clinical and immunopathological aspects 1987 Springer-Verlag Berlin 61 82
3. Moutsopoulos H.M. Sarmas J.H. Talal N. Is central nervous system involvement a systemic manifestation of primary Sjögren's syndrome? Rheum Dis Clin North Am 19 1993 909 912
4. Alexander E.L. Ranzenbach M.R. Kumar A.J. Anti-Ro (SS-A) autoantibodies in central nervous system disease associated with Sjögren's syndrome (CNS-SS): clinical, neuroimaging, and angiographic correlates Neurology 44 1994 899 908
5. Alexander E.L. Neurology disease in Sjögren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle Rheum Dis Clin North Am 19 1993 869 908
6. Drosos A.A. Andonopoulos A.P. Lagos G. Andonopoulos N.V. Moutsopoulos H.M. Neuropsychiatric abnormalities in primary Sjögren's syndrome Clin Exp Rheumatol 7 1989 207 209
7. Skopouli FN, Dafni U, Ioannidis JPA, Moutsopoulos HMM. Clinical evolution, and morbidity and mortality impact of primary Sjögren's syndrome (submitted for publication).
8. Dafni U. Tzioufas A.G. Staikos P. Skopouli F.N. Moutsopoulos H.M. The prevalence of Sjögren's syndrome in a close rural community Ann Rheum Dis 56 1997 521 525
9. Ioannidis J.P.A. Lau J. Uncontrolled pearls, controlled evidence, meta-analysis and the individual patient J Clin Epidemiol 52 1998 709 711
10. Miro J. Pena-Sagredo J.L. Bercano J. Prevalence of primary Sj6gren's syndrome in patients with multiple sclerosis Ann Neurol 27 1990 582 584
11. Metz L.M. Seland T.P. Fritzlelm S. An analysis of the frequency of Sjögren's syndrome in a population of multiple sclerosis patients J Clin Lab Immunol 30 1989 121 125
12. Montecucco C. Franciotta D.M. Caporali R. Sicca syndrome and anti-SSA/Ro antibodies in patients with suspected or definite multiple sclerosis Scand J Rheumatol 18 1989 407 412
13. Noseworthy H.J. Bass B.H. Vandervoort M.K. The prevalence of primary Sjögren's syndrome in a multiple sclerosis population Ann Neurol 29 1989 95 98
14. Linardaki G. Skopouli F.N. Koufos C. Moutsopoulos H.M. Subclinical multisystemic autoimmunity presenting as a progressive myelopathy Lupus 6 1997 675 677
15. Dalakas M.C. Polymyositis-dermatomyositis 1988 Butterworth Boston, MA
16. Vitali C. Bombardieri S. Moutsopoulos H.M. Preliminary criteria for the classification of Sjögren's syndrome: results of the EEC prospective concerted action Arthritis Rheum 36 1993 340 347
17. Vitali C. Bombardieri S. Moutsopoulos H.M. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospectivemulticentre study Ann Rheum Dis 55 1996 116 121
18. Moutsopoulos H.M. Chused T.M. Mann D.L. Sjögren's syndrome (sicca syndrome): current issues Ann Intern Med 92 1980 212 226
19. Moutsopoulos H.M. Manoussakis M.N. Lumping or splitting autoimmune rheumatic disorders? Lessons from Sjögren's syndrome Br J Rheumatol 37 1998 1263 1264
20. Ioannidis J.P. Lau J. Heterogeneity of the baseline risk within clinical trial populations: a proposed evaluation algorithm Am J Epidemiol 148 1998 1117 1126
21. Tzioufas A.G. Boumba D.S. Skopouli F.N. Moutsopoulos H.M. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predicting factors for development of lymphoma in primary Sjögren's syndrome Arthritis Rheum 39 1996 767 772
22. Steinman L. Autoimmune disease Sci Am 269 1993 75 83